Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Treat Rev. 2007 Dec;33(8):704-9. Epub 2007 Oct 22.

Targeting ALT: the role of alternative lengthening of telomeres in pathogenesis and prevention of cancer.

Author information

  • 1Asklepios Klinik Altona, Department of Hematology and Internal Oncology, Paul-Ehrlich-Strasse 1, 22763 Hamburg, Germany. f.mathiasbollmann@web.de

Abstract

Telomere shortening in the course of cell divisions plays an important role in both suppression and pathogenesis of cancer. Telomere maintenance mechanisms such as telomerase and alternative lengthening of telomeres (ALT) are essential for long-term tumor growth. Consequently, interdiction of telomere lengthening has been proposed as an anti-cancer treatment but requires insight in the genes and pathways involved. In this article, the molecular and functional details of ALT are reviewed, and proposed next steps towards a therapy aimed at preventing ALT in human cancers are described.

PMID:
17933469
DOI:
10.1016/j.ctrv.2007.08.006
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center